# AMN Healthcare to Hold Fourth Quarter and Full Year 2025 Earnings Conference Call on Thursday, February 19, 2026
Canonical URL: https://biopharmsignal.com/news/AMN/amn-healthcare-to-hold-fourth-quarter-and-full-year-2025-earnings-conference-cal-904c3bd0
Ticker: AMN
Company: AMN Healthcare
Source: AMN Healthcare
Published: 2026-01-23 12:30 EST
## Summary

AMN Healthcare Services, Inc. (NYSE: AMN), has scheduled a conference call to discuss its fourth quarter and...

## Article Body
AMN Healthcare Services, Inc. (NYSE: AMN), has scheduled a conference call to discuss its fourth quarter and full year 2025 financial results and first quarter 2026 outlook on Thursday, February 19, 2026, at 5:00 p.m. Eastern Time. On the same day, the Company also expects to issue an earnings news release after market close at approximately 4:15 p.m. Eastern Time.

A live webcast of the call can be accessed through this webcast link , which also will be available on AMN Healthcare’s investor relations website . Interested parties may participate live via telephone by registering at this conference call link . Please follow the link and register with a valid e-mail address. A PIN will be provided to you with dial-in instructions. If you lose track of these details, please re-register at the conference call link above.

Following the conclusion of the call, a replay of the webcast will be available at the Company’s investor relations website, http://ir.amnhealthcare.com .

About AMN Healthcare

AMN Healthcare is the leader and innovator in total talent solutions for healthcare, bringing together the people, processes and technology to deliver better care. Through a steadfast partnership approach, we solve the most pressing workforce challenges to enable better clinical outcomes and access to care. In 2025 our healthcare professionals reached millions of patients at more than 2,000 healthcare systems, including 87 percent of the top systems nationwide. We provide a comprehensive network of quality healthcare professionals and deliver a fully integrated and customizable suite of workforce technologies. For more information, visit www.amnhealthcare.com .

The Company’s common stock is listed under the symbol “AMN” on the New York Stock Exchange. For more information about AMN Healthcare, visit www.amnhealthcare.com, where the Company posts news releases, investor presentations, webcasts, SEC filings and other material information. The Company also utilizes email alerts and Really Simple Syndication (“RSS”) as routine channels to supplement distribution of this information. To register for email alerts and RSS, visit http://ir.amnhealthcare.com .

Contact: Randle Reece Vice President, Investor Relations and Strategy 866-861-3229 Web site: http://www.amnhealthcare.com
## Recent Company News
- 2026-06-09 13:00 EST — [AMN Healthcare Acquires Jaide Health to Expand Language Access Across the Patient Journey Through AI Technology](https://biopharmsignal.com/news/AMN/amn-healthcare-acquires-jaide-health-to-expand-language-access-across-the-patien-ca9f1e96) — Source: AMN Healthcare
- 2026-05-13 14:02 EST — [Eric Palmer Joins AMN Healthcare Board of Directors](https://biopharmsignal.com/news/AMN/eric-palmer-joins-amn-healthcare-board-of-directors-b98bda3c) — Source: AMN Healthcare
- 2026-05-07 20:15 EST — [AMN Healthcare Announces First Quarter 2026 Results](https://biopharmsignal.com/news/AMN/amn-healthcare-announces-first-quarter-2026-results-69e52158) — Source: AMN Healthcare
- 2026-04-09 11:30 EST — [AMN Healthcare to Hold First Quarter 2026 Earnings Conference Call on Thursday, May 7, 2026](https://biopharmsignal.com/news/AMN/amn-healthcare-to-hold-first-quarter-2026-earnings-conference-call-on-thursday-m-09f1e3de) — Source: AMN Healthcare
- 2026-02-26 15:00 EST — [AMN Healthcare Survey Reveals Sharp Divide Between Leaders’ Organizational Confidence and Industry Outlook for 2026](https://biopharmsignal.com/news/AMN/amn-healthcare-survey-reveals-sharp-divide-between-leaders-organizational-confid-69477fad) — Source: AMN Healthcare
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)